The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
The Animal Enterprise Terrorism Act was signed into lawï¾
On Nov. 27, 2006, the Animal Enterprise Terrorism Act (AETA) was officially signed into law by President George…
Biotechnology | Diagnostics | Genomics | Life Science News | NIH | Non-Profit Research | Therapeutics | U.S. Congress
Washington University received its largest grant ever for the Genome Sequencing Center
On Nov. 20, 2006, the Genome Sequencing Center at Washington University School of Medicine in St. Louis announced…
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
The FDA approved Gleevec, a drug developed by the OHSU Cancer Institute, for five cancers
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
The National Cancer Institute released preliminary data on genetic susceptibility for prostate cancer
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
Trubion Pharmaceutical completed its IPO
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
ICOS Corp announced agreement to be acquired by Eli Lilly and Company
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
NIH announced two integral components of the Cancer Genome Atlas Pilot Project
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
The Biomarkers Consortium was founded
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
National Cancer Institute scientists identified novel protein that ties disruption of critical cellular pathway to Birt-Hogg-Dub syndrome
On Oct 2, 2006, National Cancer Institute researchers have linked specific genetic mutations to defects in cells that…
The Virginia Bioinformatics Institute opened new office complex in the National Capital Region
On Sept. 28, 2006, the Virginia Bioinformatics Institute (VBI) opened its new office complex in the National Capital…
The National Cancer Institute created network of clinical proteomic technology centers for cancer research
On Sept. 27, 2006, the National Cancer Institute announced funding for a major component of its $104 million,…
The Allen Institute for Brain Science Completed the Brain Atlas
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
Integrated DNA Technologies acquired Belgian manufacturer and established European operating base in Leuven, Belgium
On Sept. 18, 2006, Integrated DNA Technologies (IDT) announced the acquisition of RNA-TEC, based in Leuven, Belgium. The…
BD acquired TriPath Imaging for $350 million
On Sept. 8, 2006, BD (Becton, Dickinson) announced an agreement to acquire the 93.5% of the outstanding shares…
The National Cancer Institute Annual Report to the Nation found cancer death rates continue to drop
On Sept. 6, 2006, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
National Cancer Institute researchers developed a new model for estimating the 5-year risk of melanoma
On Sept. 1, 2006, National Cancer Institute researchers developed a new model for estimating the 5-year risk of…
Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated
On Aug. 23, 2006, the Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated. Designed as a national…
John E Niederhuber became the thirteenth director of the National Cancer Institute
On Aug. 16, 2006, President Bush announced that he intended to appoint John E. Niederhuber, M.D., to be…
National Cancer Institute researchers discovered unique pattern of gene activity that predict liver cancer spread
On Aug. 14, 2006, National Cancer Institute (NCI) researchers announced they had found a unique pattern of activity…
Corus Pharma was acquired by Gilead Sciences for $365 million
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
Biotechnology | Diagnostics | Life Science News | Non-Profit Research | Pharmaceutical | Therapeutics
The Frances Langford Heart Center opened its doors
On Aug. 1, 2006, the Frances Langford Heart Center opened its doors bringing open-heart surgery and interventional cardiology…
Sandia work on space shuttle showed live cells influence growth of nanostructures
On Jul. 20, 2006, Sandia and the University of New Mexico reported that experiments involving single-cell organisms in…
Alaska Airlines awarded E. Donnall Thomas Medal of Achievement Medal
On Jul. 18, 20006, the Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement…
Eli Lilly and Company’s Gemzar was approved for use in the treatment of women living with recurrent ovarian cancer
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved for use in the treatment of women…
Genentech drug Lucentisï¾™ (ranibizumab injection) was approved
On Jun. 30, 2006, Genentech drug Lucentisï¾™ (ranibizumab injection) was approved by the FDA for the treatment of…
The National Cancer Institute scientists identified an inherited gene that strongly affects risk for the most common form of melanoma
On Jun. 29, 2006, researchers at the National Cancer Institute have identified a link between inherited and acquired…
ACIP recommends second dose of varicella vaccine for children
On Jun. 29, 2006, the Immunization Practices Advisory Committee (ACIP) recommends second dose of varicella vaccine for children.